| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |